News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Pre-Clinical (World)
TopiVert Completes TOP1630 Preclinical Development 5/16/2016
Can-Fite BioPharma (CFBI) To Present Data On Cf602 In The Treatment Of Erectile Dysfunction At American Urological Association's Annual Meeting 5/2/2016
NeuroVive (NVP) Starts Preclinical TBI Program In Collaboration With University of Pennsylvania 4/26/2016
Affimed (AFMD) Presents Data On AFM13-Mediated Innate/Adaptive Immune Crosstalk At The AACR Annual Meeting 2016 4/21/2016
Affimed (AFMD) Presents Data On EGFRwt and EGFRvIII-Targeting NK- And T-Cell Tandabs At The AACR Annual Meeting 2016 4/21/2016
Combinations Of Viralytics Ltd (VLA.AX) CAVATAK And Checkpoint Immunotherapy Demonstrate Anti-Cancer Activity In Preclinical Lung Cancer And Melanoma Studies 4/19/2016
Compugen Ltd. (CGEN) Achieves Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer (BAY) 4/18/2016
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Research At The 2016 AACR Annual Meeting 4/18/2016
BerGenBio AS Presents New Data Demonstrating That BGB324 Enhances Checkpoint Inhibitor Blockade 4/18/2016
Can-Fite BioPharma (CFBI) Announces New Pre-Clinical Data For CF602 Demonstrating Statistically Significant Full Recovery From Erectile Dysfunction After A Single Dose 4/11/2016
NewPhase Successfully Completed Small Mammal Pre-Clinical Trials Of A Cancer Treatment That Transforms Cancer To A Treatable Chronic Ailment 4/11/2016
OWC Pharmaceutical Research Corp. Advances Its Multiple Myeloma Study To Animals 3/29/2016
BioCad Release: Innovative Russian Medicine Mobilizes Human Immune System To Fight Cancer 3/23/2016
Can-Fite BioPharma (CFBI) To Present At BIO CEO & Investor Conference In New York City On February 8, 2016 2/5/2016
Allergan (AGN) Release: Rapastinel (GLYX-13) Shown To Improve Ketamine Or PCP-Induced Cognitive Impairment In Mice 1/19/2016
Glide Technologies Announces Successful Proof-Of-Concept With Novel Exenatide Solid Dose Formulation 1/6/2016
Akari Therapeutics Announces Additional Data From Non-Human Primate Safety Study Demonstrating Equivalent Coversin Efficacy In Both Elisa CH50 And Hemolytic SRBC Assays 1/5/2016
Preclinical Validation Of Oncodesign SA’s First Radiotracer Prior To Human Application 12/17/2015
AstraZeneca PLC (AZN)'s New R&D Approach Involves Diving into the Secretome 12/14/2015
BioLineRx Ltd. To Host Investor Breakfast In New York On December 3, 2015 11/25/2015
MGB Biopharma Limited Successfully Completes Feasibility Study With Topical Formulation Of Its Lead Antibacterial MGB-BP-3 11/17/2015
PHARNEXT's Pleodrug PXT-864 Demonstrates Positive Effects In Parkinson's Disease Preclinical Data Published In Nature's Scientific Reports 11/10/2015
Virttu Biologics Shows Robust Evidence Of Immunological Activity In Mesothelioma Patients Following SEPREHVIR Administration Results To Be Presented At Society For ImmunoTherapy Of Cancer (SITC) 11/5/2015
Hutchison China MediTech (Chi-Med) Release: Sulfatinib Clinical Results And Fruquintinib-Savolitinib Combination Preclinical Results To Be Presented At The 2015 AACR-National Cancer Institute-EORTC Molecular Targets And Cancer Therapeutics Conference 10/30/2015
Clasado And University of Oxford Demonstrate Latest Series Of Effects Of Advanced Prebiotic On Neuro-Inflammation And Anxiety In Pre-Clinical Study 10/27/2015
Probiodrug AG Presented Data On Its pglu-3 Abeta Monoclonal Antibody At Neuroscience 2015, Chicago 10/19/2015
OncoQR’s Breast Cancer Vaccine Successfully Completes Pre-Clinical Proof-of-Concept Study 10/15/2015
Kuros Biosurgery AG To Present Positive kur-115 Pre Clinical Data For Interbody Spinal Fusion Treatment At The 2015 North American Spine Society 10/15/2015
Addex Therapeutics (ADXN.SW)' ADX71441 Demonstrates Robust Efficacy In Multiple Preclinical Models Of Alcohol Use Disorder 10/13/2015
Protalix Biotherapeutics, Inc. (PLX) To Explore Non Alcoholic Steato Hepatitis (NASH) As An Indication For Its PRX 106 Oral Anti TNF 10/5/2015
Addex Therapeutics (ADXN.SW) ADX71149 Demonstrates Synergistic Efficacy With Levetiracetam In Preclinical Models Of Epilepsy 9/23/2015
BerGenBio AS Release: BGB324 Enhances Immune Checkpoint Inhibitor Efficacy In Preclinical Cancer Models 9/21/2015
Summit Therapeutics Presents New Positive Preclinical Data On Novel C. difficile Antibiotic SMT19969 At ICAAC 2015 9/18/2015
Debiopharm And Solid Biosciences, LLC, Announce A Collaboration To Explore The Use Of Alisporivir (Debio 025) In Muscular Dystrophy 9/8/2015
Novogen Limited (NVGN) Announces The Outcome Of A Comprehensive Science Review 8/31/2015
greenovation Biotech GmbH Release: Fabry Enzyme Replacement Therapy (ERT) Based On Mannose-Mediated Cellular Uptake Shows Encouraging Preclinical Results That Allow Start Of Early Clinical Trials 8/27/2015
Amarantus BioSciences, Inc. Announces A New Eltoprazine Publication Confirming The Long-Term Efficacy And Elucidating The Mechanism Of Action In PD-LID 8/5/2015
GenKyoTex S.A. ’s NOX1&4 Inhibitor Strategy In Liver Fibrosis Supported By New Preclinical Results 7/30/2015
New Data Show Pluristem Therapeutics (PSTI)s PLX Cells Regulate The Immune System 7/27/2015
Yissum Ltd. Introduces A Novel Technology For Drug Screening And Testing Of Orphan Diseases Without Utilizing Animal Models 7/27/2015
CEVEC Pharma's CAP(R)Go Derived Recombinant Placental Human Alkaline Phosphatase Shows Superior Results In A Preclinical Study 7/6/2015
Can-Fite BioPharma (CFBI)'s CF602 Sexual Dysfunction Drug Backed By New Preclinical Data Progresses Towards An IND 6/29/2015
BioBlast Pharma (ORPN) Announces Positive Preclinical Proof-Of-Concept Results Of Its Novel Read-Through Platform In Spinal Muscular Atrophy (SMA) 6/22/2015
BioBlast Pharma (ORPN) To Present Preclinical Proofs Of Concept In Spinal Muscular Atrophy And Friedreich's Ataxia At Two Leading Scientific Meetings In June 6/18/2015
Bionomics Limited (BNO.AX) Files Patent For Use Of BNC105 In Combination With PD-1 And CTLA-4 Immuno-Oncology Antibodies 6/15/2015
Tikcro Technologies To Proceed With CTLA4 And PD1 Antibody Generation Plan 6/15/2015
Protalix Biotherapeutics, Inc. (PLX) Announces AIR Dnase Data Presented At The 38th European Cystic Fibrosis Conference 6/12/2015
Presentations On Two Novel Zealand Pharma  (ZEAL.CO) Preclinical Peptide Therapeutics As Possible Approaches For The Treatment Of Type 2 Diabetes And Obesity At The American Diabetes Association's 74th Scientific Sessions 6/8/2015
MGB Biopharma Limited Succeeds In Developing An IV Formulation Of MGB-BP-3 For The Treatment Of Systemic Susceptible And Resistant Gram-Positive Hospital-Acquired Infections 6/2/2015
Genticel Announces Positive Preclinical Proof Of Concept Results Of GTL002, Its New Multivalent HPV Therapeutic Vaccine Candidate Based On Company's Versatile Vaxiclase Platform 6/1/2015
Onxeo Announces Preclinical & Clinical Data From Three Studies Supporting The Potential For Belinostat In Multiple Orphan Oncology Indications 5/28/2015
Zealand Pharma  (ZEAL.CO) Starts Clinical Development Of A Multiple-Dose Version Of Its Stable Glucagon Analogue, ZP4207 5/20/2015
Novogen Limited (NVGN) Release: Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells 5/8/2015
Cell Cure Neurosciences Announces Preclinical Efficacy Data Demonstrating Opregen Preserves Vision 5/4/2015
Medivir AB (MVRBF): Positive Preclinical Antiviral And Safety Profile Of MIV-802 Supports Continued Development 4/23/2015
TRANSGENE (ENX:TNG) Presents New Data With TG1050, An Immunotherapy Being Developed To Treat Chronic Hepatitis B, At The International Liver Congress 2015 4/23/2015
DelMar Pharmaceuticals Presents Positive Preclinical Data On Val-083 For Treatment Of Non-Small Cell Lung Cancer At AACR Annual Meeting 4/20/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Data At The 2015 AACR Annual Meeting 4/20/2015
Debiopharm Announces Results Of 2 Key Oncology Programs At 2015 American Association for Cancer Research Conference 4/16/2015
BioBlast Pharma (ORPN) Announces Positive In Vivo Preclinical Proof-Of-Concept Results Of Its Cabaletta Platform In Spinocerebellar Ataxia Type 3 (SCA3) 3/30/2015
Tekmira (TKMR) Presents Preclinical Results Demonstrating Super-Additive Effects On Plasma Triglyceride Lowering By Silencing Of Apoc3 And ANGPTL3 Genes 3/26/2015
Sangui BioTech International Inc. (SGBI): Series Of Preclinical Trials Concluded Successfully 3/18/2015
Greenovation Biotech GmbH Successfully Completes Preclinical Toxicology Studies Of Alpha - Galactosidase 3/10/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Preclinical Data On The Combination Of REOLYSIN And Radiotherapy In Melanoma At The Irish Association For Cancer Research Conference 3/5/2015
Sirona Biochem: Positive Preclinical Toxicology Results For Its SGLT2 Inhibitor Trigger Milestone Payment From Wanbang Biopharmaceuticals 3/4/2015
Addex Therapeutics (ADXN.SW) mGluR2 NAM Demonstrates Protection In Preclinical Model Of Ischemic Neuronal Death 2/19/2015
Significant Findings In NIH's Trial Of Pluristem Therapeutics (PSTI)'s PLX-R18 Cells For Treatment Of Acute Radiation Syndrome 2/18/2015
Iomet Pharma Demonstrates Superior In Vivo PK/PD Properties In Pre-Clinical IDO, TDO And Dual IDO/TDO Cancer Immunotherapy Programs 2/11/2015
Two of Roche (RHHBY)'s Experimental Parkinson's Drugs Caused Lung Toxicity in Monkeys 2/9/2015
The Journal Diabetes Publishes Pre-Clinical Data On Cortendo’s Novel Diabetes Treatment, BP-2001 1/28/2015
Can-Fite BioPharma (CFBI)'s CF602 Demonstrates Efficacy In Treatment Of Sexual Dysfunction In Preclinical Studies 1/27/2015
Dry Eye Syndrome: Neuroptis Biotech Successfully Completes The Pre-Clinical Phase For ML7 1/21/2015
Novartis AG (NVS) Researchers Claim to Have Discovered "Fountain of Youth" Drug 1/5/2015
Novogen Limited (NVGN) Announces Breakthrough Discovery In The Treatment Of Melanoma 12/16/2014
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014
Admedus HPV Vaccine Heads To The Clinic 11/24/2014
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014
AM-Pharma Holding BV Presents Preclinical Data On Mode-Of-Action For recAP In Acute Kidney Injury At American Society of Nephrology Meeting 11/13/2014
nanoMR Inc. Lands $21.5 Million Deal 11/7/2014
Ablynx (ABLYF) To Present Pre-Clinical Proof-Of-Concept Results With Anti-Rsv Nanobody, Alx-0171, At 9th International Respiratory Syncytial Virus Symposium 11/6/2014
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib 10/31/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators 10/14/2014
Compugen Ltd. (CGEN) Achieves Second Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer AG (BAYZF) 10/14/2014
Kadimastem Received A Quick Response From The FDA: The Development Process For The Stem Cell-Based Drug For ALS Is Expected To Be Significantly Shortened 10/7/2014
Immunovaccine Inc. To Provide Update On Ongoing Ebola Virus And Cancer Vaccine Programs At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
Cell Reports Publication On The Mechanism Of Action Of NOXXON’s Anti-SDF-1 Spiegelmer® Olaptesed Pegol (NOX-A12) In Preclinical Multiple Myeloma Models 9/26/2014
Sirona Biochem Launches Anti-aging Preclinical Studies 9/23/2014
Novartis AG (NVS) Studies Muscle Atrophy By Sending Mice Into Space 9/23/2014
OxThera, Inc. Release: Oxabact® Granted European Medicines Agency Orphan Drug Designation For Treatment Of SBS 9/23/2014
BioLineRx Ltd. Presents Positive Preclinical Results In Treatment For AML Patients With FLT3 Mutations 9/17/2014
GlaxoSmithKline (GSK)'s Experimental Ebola Vaccine Protects Monkeys For 10 Months 9/8/2014
GamaMabs Pharma SA Announces Two Scientific Communications On Its AMHR2 Project 9/4/2014
Sirona Biochem Announces Positive Results In PK Study For Type 2 Diabetes 9/4/2014
Ebola Vaccine Using Immunovaccine Inc.’s DepoVax Proves Highly Efficacious In Non-Human Primate Study 8/25/2014
Stemedica International Announces Pre-clinical Data Of Its Alzheimer’s Study 8/20/2014
CrystalGenomics Release: Polmacoxib Demonstrates Prevention And Treatment Effects In Colorectal Cancer 8/13/2014
Scancell Release: Synergy Of SCIB1 With Checkpoint Inhibitors 8/12/2014
Cannabis Science Inc. Initiates Pre-Clinical Studies On Cannabinoid Formulations In Neurological Diseases Including Sleep Disorders With The Highly Reputable Institute For Health And Science On Ageing - INRCA - In Italy 8/4/2014
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide 7/22/2014
Addex Therapeutics (ADXN.SW) ADX71441 Positive Results In Preclinical Model Of Nicotine Addiction 7/10/2014
TRANSGENE (ENX:TNG) Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China 7/1/2014
BiOptix And Altermune Technologies Present At Drug Analysis 2014 6/27/2014
RedHill Biopharma Ltd. (RDHL) Announces Positive Preliminary Pre-Clinical Data With RHB-104 For The Treatment Of Type 1 Diabetes 6/26/2014
Apitope Progresses Graves' Disease Treatment 6/19/2014
Success In Kadimastem’s First Pre-Clinical Trial For Treatment Of Amyotrophic Lateral Sclerosis (ALS) 6/19/2014
Zealand Pharma  (ZEAL.CO) Presented New Data On Two Novel Peptide Therapeutics From Its Preclinical Diabetes Pipeline At The American Diabetes Association 74th Scientific Sessions 6/17/2014
Five Scientific Communications At The European Academy Of Allergy And Clinical Immunology Congress Further Support DBV Technologies's EPIT™ Disease Modifying Effect 6/11/2014
Cellectis And Accelera (Nerviano Medical Sciences (NervianoMS)) Sign An Agreement To Complete Preclinical Studies Of Cellectis’ Lead Product Candidate UCART19 6/5/2014
Galmed Pharmaceuticals Release: Recently Published Independent Research Supports The Importance Of Reverse Cholesterol Transport On NASH Pathogenesis 6/4/2014
Implandata Successfully Launched Pre-Clinical Studies For New To The World Implantable 24h Extraocular Sensor For Intraocular Pressure Measurement At Glaucoma Patients 6/3/2014
Theralase Technologies Inc. (TLT.V) Discovers Anti-Cancer Memory Response 6/2/2014
Novogen Limited (NVGN) Identifies Highly Active Drug Candidates Against Prostate Cancer 5/27/2014
Da Volterra Presents New Data Supporting DAV132 As A Promising Candidate To Protect The Intestinal Flora And Prevent Severe Clostridium Difficile Infections 5/12/2014
Apitope Initiates Preclinical Development Of Peptide Therapy, ATX-F8-117, To Treat Factor VIII Intolerance 5/7/2014
Albireo’s Lead Compound In Cholestatic Liver Diseases, A4250, Protects Against Bile Acid-Mediated Cholestatic Liver Injury In Mice 4/11/2014
ERYtech Pharma Picks Up A New Candidate For Its Tumor Starvation Pipeline 4/9/2014
Domainex Ltd Programme Shows Great Promise For The Treatment Of Inflammatory Diseases, Such As Chronic Obstructive Pulmonary Disease (COPD) 4/7/2014
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Toxicology Study Main Findings 4/1/2014
Patrys Limited (PAB.AX) PAT-LM1 Advancing To The Clinic 3/24/2014
Novagen, Inc. And CanTx Experimental Drug, Trx-1, Proves Effective In Vivo 3/18/2014
Kymab Announces Publication Of The Kymouse Technology In Nature Biotechnology 3/17/2014
Preclinical Results For Pluristem Therapeutics (PSTI)'s PLX-PAD Cells In Tendon Injury Presented At American Academy of Orthopaedic Surgeons' Annual Meeting 3/12/2014
BioLineRx Ltd. Announces Positive Preclinical Results For Novel Treatment For Chronic Myeloid Leukemia 2/12/2014
Cellectis Grants genOway An Exclusive Sublicense For Its Homologous Recombination Technology In The Field Of Genetically Modified Rodent Models 2/4/2014
GENFIT Corp. (ALGFT): Preclinical Data Support Anti-Cancer Effects Of GFT505 1/29/2014
Novozymes Biopharma Announces New Data Highlighting Potential For Monthly Drug Dosing 1/27/2014
NovoCure Ltd. Enrolls First Patient In Pilot Clinical Trial Of Novottf™ Therapy Plus Gemcitabine For First-Line Treatment Of Advanced Pancreatic Adenocarcinoma 1/24/2014
Clasado And University of Oxford Demonstrate Effect Of Prebiotics On Brain And Gut In Pre-Clinical Study 1/23/2014
NovoCure Ltd. Release: Data Published In Pancreatology Demonstrates Activity Of NovoTTF™ Therapy In Preclinical Models Of Pancreatic Cancer, Alone And In Combination With Chemotherapy 1/7/2014
Galapagos NV (GLPG.BR) Selects Pre-Clinical Candidate For Cystic Fibrosis 12/16/2013
Evotec AG (EVTG.F): Results Of Pre-Clinical Studies Lead To Reduction In Revenues, Nevertheless Profitable And More Than EURO 90 M Cash For 2013 Confirmed 12/13/2013
Evotec AG (EVTG.F) Receives Pre-Clinical Milestone As Part Of Its Discovery Alliance With Boehringer Ingelheim Corporation 12/10/2013
Neuroptis Biotech Announces The Preclinical Results For Its Dry Eye Product ML7 11/12/2013
AM-Pharma Holding BV Presents Positive Data From recAP Preclinical Study at American Society of Nephrology Meeting 11/8/2013
"New" Infectious Diseases: Clinical Tests on Innovative Themis Vaccine 11/7/2013
AIMM Therapeutics' Pre-Fusion RSV Antibodies Facilitate Improved Approach to Vaccine Development 11/4/2013
Ablynx (ABLYF) to Present Pre-clinical Proof-of-Concept Data on ALX-0761 at American College of Rheumatology 10/28/2013
S-TARget Achieves Clinical Proof of Concept for Allergy Vaccine SG100 in Asthmatic Non-Human Primates 10/10/2013
Medivir AB (MVIRb.F): MIV-247 Has Been Selected as a Candidate Drug and Enters Development for the Treatment of Neuropathic Pain 10/10/2013
Compugen Ltd. (CGEN) Drug Candidate Demonstrates High Effectiveness in Type I Diabetes Animal Model 10/9/2013
Addex Therapeutics (ADXN.SW) ADX71441 Dose Dependently Reduced PMP22 Expression Comparable to Baclofen in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease 10/3/2013
Zealand Pharma  (ZEAL.CO) Presents New Preclinical Data on its GLP-1-Gastrin Dual Agonist, Which Shows Potential as a Novel Approach for the Treatment and/or Prevention of Type 2 Diabetes 9/26/2013
Compugen Ltd. (CGEN) Target for Cancer Immunotherapy Shown to Affect Multiple Immune Cell Types Involved in Tumor Progression 9/17/2013
PRECOS Highlights Latest Advances in PDX Modelling for Oncology Drug Discovery to Increase Effectiveness of Drugs for Cancer Patients 9/13/2013
Karo Bio AB Receives Funding From the National MS Society to Develop ERbeta Agonists for Treatment of Progressive Multiple Sclerosis 9/12/2013
Alcobra (ADHD)'s Pre-Clinical Fragile X Study for MG01CI Shows Significant Positive Results 9/10/2013
Chronic Treatment With Addex Therapeutics (ADXN.SW) Dipraglurant Rescues Impairment of Long-Term Synaptic Plasticity in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 9/4/2013
Coffee and Tea May Contribute to a Healthy Liver, Duke-NUS Graduate Medical School Study 8/16/2013
Rib-X Pharmaceuticals, Inc. Presents Data Demonstrating Potent In Vitro Activity of Delafloxacin Against Drug-Resistant Gonorrhea 7/16/2013
VBL Therapeutics Discloses Data About VB-201 Novel Mechanism and Pre-Clinical Efficacy in Atherosclerosis 7/8/2013
Cellectis Announces Groundbreaking in Vivo Proof of Concept Testing of Their Flagship UCART19 Product for Curative Therapy of Leukemia 7/8/2013
Pluristem Therapeutics (PSTI)'s Preclinical Results for Its PLX-RAD Cells Published in the Journal PLOS ONE 6/20/2013
TG Therapeutics, Inc. (MHA) Announces Presentation of Pre-Clinical Data on the Combination of TG-1101 and TGR-1202 at the International Conference on Malignant Lymphoma, Lugano, Switzerland 6/20/2013
Novartis AG (NVS) Ramps Up Alzheimer's Drug Pursuit as Rivals Fail 5/24/2013
Arsanis, Inc. Nominates Preclinical Candidate for Staphylococcus aureus Program 5/23/2013
H. Lundbeck A/S (LUN.CO) Release: Vortioxetine, a New Multimodal Agent in Development for the Treatment of Major Depression, Shows Effects on Cognitive Function in Several Preclinical Animal Models 5/22/2013
Merck & Co., Inc. (MRK), Bristol-Myers Squibb Company (BMY) and Roche (RHHBY)'s Human Immune-Boosting Cancer Drugs Seen Extending Lives 5/15/2013
Pluristem Therapeutics (PSTI) Release: Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia 5/13/2013
Starpharma Holdings Ltd's Dendrimer a Potential Viral Conjunctivitis Treatment 5/13/2013
Addex Therapeutics (ADXN.SW) Reports that Dipragluant Demonstrated Dose-Dependent mGlu5 Receptor Occupancy in a Non-Human Primate PET Study 5/1/2013
Evotec AG (EVTG.F): New Hormone to Treat Diabetes Published in "Cell" 4/26/2013
NicOx SA (COX.PA) Release: Pre-Clinical Results on Naproxcinod in Models of Muscular Dystrophy Presented at Muscular Dystrophy Association Scientific Conference 4/24/2013
Addex Therapeutics (ADXN.SW) Dipraglurant Normalizes Striatal Cholinergic Dysfunction in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 (DYT1) 4/18/2013
Data on SEEK's Novel Immunotherapy for HIV Published in Virology Journal Antibody Treatment for HIV 4/16/2013
Innate Pharma (IPH.PA ) Presents New Data for Proprietary Programs Targeting TLR3 and KIR3DL2 4/12/2013
S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100 4/8/2013
Spirogen Ltd. and Bioatla Present Positive Data on Next-Generation Warheads in ADCS Against Cancer 4/8/2013
Successful Vaccine Developments at Themis Bioscience, Pasteur Institute Technology Proves Its Effective Potential 3/27/2013
Proteome Sciences PLC (PRM.L): Developments in Alzheimer's Disease 3/18/2013
GENFIT Corp. (ALGFT) Release: TGFTX1 Program: Successful Identification of Proprietary ROR?t Ligands for the Treatment of Auto-Immune Diseases 3/13/2013
RegeneCure's Membrane Implant Shows 40% Accelerated Healing Time of Severe Bone Fractures in Pet Clinical Study 3/12/2013
PRANA Biotechnology (PRAN)'s PBT434 Inhibits Accumulation of Parkinson's Protein and Subsequent Death of Brain Cells 3/6/2013
Starpharma Holdings Ltd Release: Dendrimers Improve Anticancer Efficacy in Lung Metastasis Model 3/4/2013
BioLineRx Ltd.'s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter the Company's Main Therapeutic Pipeline as BL-9010 2/28/2013
VIB: New Angle to Combat Malignant Brain Tumors in Children 2/28/2013
Roche (RHHBY) Research Sheds Light on Improving Neurological Deficits in Mouse Model of Down Syndrome 2/27/2013
Circassia Limited's Cat Allergy Treatment Shows Sustained Symptom Improvement 2/25/2013
Anergis Presents Preclinical Data of its Ragweed Allergy Vaccine Candidate AllerR 2/21/2013
Orion Corporation Release: Promising Preclinical and Phase I Data of a New Generation Androgen Receptor (AR) Inhibitor, ODM- 201, Presented at American Society of Clinical Oncology GU 2013 Symposium 2/15/2013
Mireven Announces Positive In-Vitro Results for miRNA-7-5p in Melanoma 2/12/2013
BioDiem Ltd. (BDM.AX) Progresses to Proof-of-Concept Testing of BDM-I Antimicrobial Effect Against Parasites 2/8/2013
BioDiem Ltd. (BDM.AX)'s Antimicrobial Tested as Treatment for TB, Fungal Infections, in National Institutes of Health (NIH) Research Program 2/1/2013
Addex Therapeutics (ADXN.SW) Dipraglurant Reduces Motor Abnormalities in a Preclinical Model Relevant for Several Rare Types of Dystonia 1/29/2013
Cellmid Records Positive Data in Midkine Antibody Study in Kidney Disease 1/24/2013
Open Monoclonal Technology and Recombinant Antibody Technology Announce OmniRa™ Scientific Publication 1/22/2013
BrainStorm Cell Therapeutics Inc. Establishes Safety of Repeat Doses of NurOwn in Mice; Pre-clinical Study Conducted at GLP-Compliant Harlan Laboratories, Inc. 1/10/2013
Addex Therapeutics (ADXN.SW) Announces Positive Data With ADX71441 in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease 1/7/2013
AMS Biotechnology (AMSBIO) Release: Integrating Extracellular Matrix Into 3D Spheroid Culture for a High Throughput Cell Invasion Assay 12/21/2012
AMS Biotechnology (AMSBIO) Researchers Respond Enthusiastically to Alvetex 3D Cell Culture 12/14/2012
BiondVax Pharmaceuticals' Universal Influenza Vaccine M-001 Significantly Enhances the Efficacy of the Human Pandemic H5N1 Bird Flu Vaccine 12/13/2012
Journal of Huntington's Disease Publishes Benefits of PRANA Biotechnology (PRAN)'s PBT2 12/13/2012
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma 12/13/2012
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma 12/11/2012
PRANA Biotechnology (PRAN) Release: Metal Hypothesis for Alzheimer's, Huntington and Other Neurodegenerative Diseases Declared Promising Therapeutic Strategy by Scientists at New York Academy of Sciences Symposium 12/5/2012
The Staby® Technology From Delphi Genetics Efficiently Applied to DNA-Vaccine 12/3/2012
AMSilk Release: Silicone Breast Implants With Spider Silk-Based Coating Show Reduced Side-Effects in Preclinical Studies 11/30/2012
Galapagos NV (GLPG.BR) Discovers Novel Class of Antibiotics 11/26/2012
Poor Sleep Can Lead to Schizophrenia Symptoms, University of Bristol Study 11/15/2012